ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.65%69.851.0%$924.33m
AMGNAmgen Inc.
0.62%173.170.8%$639.72m
BIIBBiogen Inc.
-0.41%288.940.9%$540.40m
CELGCelgene Corporation
2.07%121.121.0%$493.50m
REGNRegeneron Pharmaceuticals, Inc.
-0.49%371.181.9%$343.16m
ALXNAlexion Pharmaceuticals, Inc.
-1.20%128.822.0%$287.09m
ARIAARIAD Pharmaceuticals, Inc.
0.00%23.9813.0%$197.31m
TSROTESARO, Inc.
4.27%190.3615.3%$197.19m
INCYIncyte Corporation
0.26%120.492.3%$169.80m
ILMNIllumina, Inc.
1.28%163.373.9%$156.34m
CLVSClovis Oncology, Inc.
7.22%65.8016.4%$141.36m
VRTXVertex Pharmaceuticals Incorporated
0.72%88.332.6%$140.89m
EXELExelixis, Inc.
2.08%23.125.5%$127.23m
AAgilent Technologies, Inc.
1.53%51.621.7%$115.01m
ACADACADIA Pharmaceuticals Inc.
0.11%39.2619.0%$90.91m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.